Joao Monteiro Highlights the Value of Patient-Reported Outcomes in Clinical Trials
Joao Monteiro, Chief Editor at Nature Medicine, shared an article by Norah L. Crossnohere et al. published in Nature Medicine on LinkedIn:
”Asking patients about their symptoms, functioning and well-being during clinical trials can influence trial outcomes, regulatory decisions and clinical practice.
In a new opinion article, Norah L Crossnohere and colleagues highlight several cases when PRO endpoints in clinical trials have provided valuable insights into the benefits and burdens of interventions beyond those obtained by physiological, laboratory, clinician-reported, observer-reported or performance outcomes alone.
Read it now in Nature Medicine.”
Title: Patient-reported outcome measures add value as clinical trial endpoints
Authors: Norah L. Crossnohere, Anne L. R. Schuster, Jeffrey Bruckel, Ronald C. Chen, Amy M. Cizik, Samantha Cruz Rivera, Christopher Muth, Linda Nelsen, Derek Kyte, Albert W. Wu, Elissa Thorner, Claire Snyder, Michael Brundage
More posts featuring Joao Monteiro.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023